Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression
Language English Country Germany Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
Grant support
P30 ES00267
NIEHS NIH HHS - United States
R35 CA44353
NCI NIH HHS - United States
PubMed
10207612
DOI
10.1007/s002040050583
Knihovny.cz E-resources
- MeSH
- Benzene metabolism MeSH
- Chelating Agents pharmacology MeSH
- Cytochrome P-450 CYP2E1 biosynthesis drug effects genetics MeSH
- Ditiocarb analogs & derivatives pharmacology MeSH
- Genotype MeSH
- Glutathione pharmacology MeSH
- Immunoblotting MeSH
- Microsomes, Liver chemistry drug effects metabolism MeSH
- Kinetics MeSH
- Humans MeSH
- Methane pharmacology MeSH
- Oxidation-Reduction MeSH
- Carbon Radioisotopes MeSH
- Solubility MeSH
- Substrate Specificity MeSH
- Water MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Names of Substances
- Benzene MeSH
- Chelating Agents MeSH
- Cytochrome P-450 CYP2E1 MeSH
- dihydroxyethyldithiocarbamate MeSH Browser
- Ditiocarb MeSH
- Glutathione MeSH
- Methane MeSH
- Carbon Radioisotopes MeSH
- Water MeSH
In human liver microsomes the oxidations of benzene, chlorzoxazone, aniline, dimethylformamide, and 4-nitrophenol were significantly correlated with each other and with the level of cytochrome P450 (CYP) 2E1 estimated by immunoblotting. Moreover, benzene oxidation to water-soluble metabolites was suppressed by 0.1 mM diethyldithiocarbamate, supposedly a specific inhibitor of CYP2E1 at this level. None of these metabolic rates correlated with immunochemically determined levels of CYP1A2, 2C9, and 3A4 nor oxidation of 7-ethoxyresorufin, tolbutamide, and nifedipine. Benzene oxidation to water-soluble metabolites was characterized by typical Michaelis-Menten kinetics. The different benzene K(m) values seen in individual human microsomal samples were not correlated with the level or activity of CYP1A2, 2C9, 2E1, and 3A4 but could be due to CYP2E1 microheterogeneity. The lowest K(m) for benzene oxidation could be related to C/D and/or c1/c2 polymorphism of CYP2E1 gene. Covalent binding of benzene reactive metabolites to microsomal proteins was also correlated with the CYP2E1 metabolic rates and immunochemical levels. At high concentrations of benzene covalent binding was inversely related to benzene concentrations (as well as to formation of water-soluble metabolites) in agreement with the view that secondary metabolites, mainly benzoquinone, are responsible for the covalent binding.
References provided by Crossref.org
Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants